Skip to content

medcelerator · clinician one-pager

New Oral Medicine for Narcolepsy Type 1 in Adults

Orzeyful (oveporexton) for narcolepsy type 1

FDA Approved · United States, Canada · September 7, 2026

Condition: Narcolepsy Type 1

Who this is for

Orzeyful (oveporexton) is approved in the United States for adults with narcolepsy type 1. It cannot be sold there until the Drug Enforcement Administration schedules it. Health Canada is still reviewing it.

Next clinical step

The FDA has approved this medicine, but it can't be sold in the US until the DEA finishes classifying it as a controlled drug. Ask your doctor about timing. In Canada, authorisation is not confirmed; see Possible routes below if any are listed.

Ways to access this treatment

No treatment-specific route was found in the sources cited.

Possible routes (not confirmed)

General resources for further research

AI-produced discussion aid; not prescribing instructions. Approval does not establish coverage. Full article: https://medcelerator.com/articles/orzeyful-oveporexton